Status:
COMPLETED
Shivering Control After Percutaneous Nephrolithotomy
Lead Sponsor:
Assiut University
Conditions:
Shivering Control
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Aim of the study is comparing the effect of amino acid versus magnesium sulfate infusion on postoperative shivering in patients undergoing elective percutaneous nephrolithotomy surgery under general a...
Detailed Description
A written informed consent was taken from the patients. Patients were assigned randomly to two groups (40 subjects each) to be anesthetized and infused with either an iv amino acid starting just befor...
Eligibility Criteria
Inclusion
- ASA I-II who were listed for elective percutaneous nephrolithotomy PCNL surgery under general anesthesia.
Exclusion
- Hepatic inefficiency
- Renal inefficiency
- Spinal anesthesia because of a different mechanism of hypothermia
Key Trial Info
Start Date :
January 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04695613
Start Date
January 3 2021
End Date
April 10 2021
Last Update
June 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt, 71111